Skip to main content
Get Help Now
631-SOBERME
Professional addiction treatment for xylazine addiction - compassionate care and evidence-based recovery programs in New York
Substance

Xylazine

Xylazine is a veterinary tranquilizer increasingly found mixed with illicit opioids, causing severe complications.

Published: November 25, 2025
Last Edited: February 17, 2026
15 min read
BZ

Written by

Benjamin Zohar, NCACIP

Nationally Certified Advanced Addiction Intervention Professional

EZ

Edited by

Ezra Zohar, M.S. Ed.

Editorial Director

BM

Medically Reviewed by

Brandon McNally, RN

Medical Reviewer, ICU Critical Care Nurse

Published: November 25, 2025
Last edited: February 17, 2026
15 min read

How Xylazine Affects You

Xylazine ('tranq') is a veterinary sedative increasingly mixed with fentanyl. Causes extreme sedation, respiratory depression, amnesia, dangerously low blood pressure, and severe skin ulcers/necrosis.

Duration & Timeline

Effects begin within 10-20 minutes when injected with opioids, last 2-4 hours. Repeated use causes severe skin wounds that take weeks to heal even with treatment.

Specific Health Risks

Respiratory failure, coma, severe skin necrosis requiring amputation, bradycardia, hypothermia. Naloxone (Narcan) doesn't reverse xylazine effects—only the opioid component.

Xylazine Statistics & Research

  • • DEA reports xylazine detected in 23% of fentanyl powder and 7% of fentanyl pills tested in 2022, up from <1% in 2015
  • • CDC data shows xylazine involvement in overdose deaths increased 1,200% from 2018-2021, with highest rates in northeastern states
  • • Philadelphia studies show 90% of the illicit opioid supply contains xylazine, with severe skin wounds in 40% of users
  • • SAMHSA issued a national alert in 2023 as xylazine spread to 48 states; it's now the #1 emerging drug threat per DEA

Sources: NIDA, SAMHSA, CDC, DEA, FDA, peer-reviewed medical journals. See full references below.

Frequently Asked Questions

Why Choose Professional Treatment in New York

Professional addiction treatment provides the medical supervision, therapeutic support, and structured environment necessary for successful recovery from xylazine. Evidence-based treatment programs address both the physical and psychological aspects of addiction.

Treatment centers throughout Long Island and New York offer specialized programs accredited by The Joint Commission and licensed by the New York State Office of Addiction Services and Supports (OASAS). These facilities combine medical care, evidence-based counseling, and ongoing support to ensure the best possible outcomes for lasting recovery.

According to data from the New York State OASAS, treatment completion rates are highest when individuals receive comprehensive care that includes medical management, individual therapy, group support, and family involvement in the recovery process.

Medical References & Sources

This page contains information sourced from peer-reviewed medical literature, federal health agencies, and accredited medical institutions to ensure accuracy and compliance with E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) standards.

  1. Drug Enforcement Administration (DEA). "Xylazine Drug Fact Sheet." DEA Publications. Available at: https://www.dea.gov/factsheets/xylazine
  2. Centers for Disease Control and Prevention (CDC). "Xylazine." CDC Publications. Available at: https://www.cdc.gov/xylazine/index.html
  3. Substance Abuse and Mental Health Services Administration (SAMHSA). "Xylazine in the Drug Supply: Emerging Threat to People Who Use Drugs." SAMHSA Publications, 2023. Available at: https://www.samhsa.gov/find-help/xylazine

Medical Disclaimer

The information provided on this page is for educational purposes only and should not be considered medical advice. This page does not provide medical diagnoses, treatment prescriptions, or clinical recommendations. Always consult with qualified healthcare professionals for diagnosis and treatment of substance use disorders. If you are experiencing a medical emergency, call 911 immediately.

This content was written by certified addiction professionals and reviewed by licensed medical practitioners to ensure accuracy and adherence to current clinical guidelines. Last fact-checked: July 6, 2026.

If you or someone you know is struggling with substance use, you can reach our 24/7 confidential Long Island Rehab Helpline at 631-762-3763 for free, confidential information and treatment referral.

Get Treatment Now

Speak with a specialist about xylazine treatment options available in your area.

Call 631-SOBERME

Free & Confidential | 24/7 Support

Recovery Support Network

Long Island Rehab Helpline & Crisis Intervention connects families with trusted clinical resources across New York.

Our network includes: Intervention NY, Every1 Center, HVATC, and Long Island Addiction Treatment Resources